Cargando…
Present Molecular Limitations of ON-Bipolar Cell Targeted Gene Therapy
Recent studies have demonstrated the safety and efficacy of ocular gene therapy based on adeno-associated viral vectors (AAVs). Accordingly, a surge in promising new gene therapies is entering clinical trials, including the first optogenetic therapy for vision restoration. To date, optogenetic thera...
Autores principales: | van Wyk, Michiel, Hulliger, Elmar C., Girod, Lara, Ebneter, Andreas, Kleinlogel, Sonja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372788/ https://www.ncbi.nlm.nih.gov/pubmed/28424574 http://dx.doi.org/10.3389/fnins.2017.00161 |
Ejemplares similares
-
Empowering Retinal Gene Therapy with a Specific Promoter for Human Rod and Cone ON-Bipolar Cells
por: Hulliger, Elmar Carlos, et al.
Publicado: (2020) -
Bipolar cell targeted optogenetic gene therapy restores parallel retinal signaling and high-level vision in the degenerated retina
por: Kralik, Jakub, et al.
Publicado: (2022) -
Two Functional Classes of Rod Bipolar Cells in the Healthy and Degenerated Optogenetically Treated Murine Retina
por: Schilardi, Giulia, et al.
Publicado: (2022) -
Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy
por: Kralik, Jakub, et al.
Publicado: (2021) -
A visual opsin from jellyfish enables precise temporal control of G protein signalling
por: van Wyk, Michiel, et al.
Publicado: (2023)